Gadopentetate Dimeglumine Injection/API

更新时间：2024-04-12

地区：北京市

最小起订量：10000

月产量：100000

工厂所在地：No.3 Shuiyuan West Road, Miyun District, 101500 Beijing, China

发送询盘加到询盘篮

详细描述

包装规格：10ml:4.69 g; 12ml:5.63 g; 15ml:7.04 g; 20ml:9.38 g
付款方式：T/T, L/C
订单交货周期：Negotiation
合同定制：CRO,CMO
主要销售市场：北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲
提供样品：是

产品描述：

Since Gadopentetate Dimeglumine Injection was launched in 1992 by Beilu Pharma in China, it was highly recommended and accepted by the radiologist, and quickly occupied the market with its excellent quality and reasonable price. Up to now, it has been safely used nearly 30 years, with excellent enhancement effects and few side effects.

Product name: Gadopentetate Dimeglumine Injection

Generic name: Gadopentetate Dimeglumine Injection

Type: Injectable Contrast Media for MRI, Linear Contrast Media

No.1 market share in China

Ingredients: Gadopentetate Dimeglumine

Specification: 10ml:4.69 g; 12ml:5.63 g; 15ml:7.04 g; 20ml:9.38 g

Posology and method of administration: Intravenous injection

Adverse reactions: See the details from the package insert

Shelf life: 36 months

北京北陆药业股份有限公司 4

联系信息公司快照

● 地址：

● 城市：

● 联系人：

● 电话：

● 传真：

访问供应商商铺

成为供应商在线获取商机

申请入驻

快速询盘